Geographical information system (GIS) as a new tool to evaluate epidemiology based on spatial analysis and clinical outcomes in acromegaly

Pituitary

Volumn 18, Issue 1, 2015, Pages 8-15

  Naves, Luciana Ansaneli ^a   Porto, Lara Benigno ^a   Rosa, João Willy Corrêa ^a   Casulari, Luiz Augusto ^a   Rosa, José Wilson Corrêa ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Acromegaly; Geographical information system; Pituitary tumor registry

Indexed keywords

ACROMEGALY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; COHORT ANALYSIS; COMPUTER PROGRAM; DELAYED DIAGNOSIS; DISEASE REGISTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE ACCESS; HOME; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MIGRATION; PRIORITY JOURNAL; SPATIAL ANALYSIS; TUMOR VOLUME; MIDDLE AGED; YOUNG ADULT;

ACROMEGALY; ADOLESCENT; ADULT; AGED; BRAZIL; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84933177302     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0548-3     Document Type: Article

References (40)

1. Dworakowska D, Grossman AB (2012) The molecular pathogenesis of pituitary tumors: implications for clinical management. Minerva Endocrinol 37(2):157–172
2. Ebrahimi A, Schittenhelm J, Honegger J, Schluesener HJ (2011) Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours. J Neuroendocrinol 23(6):525–530
3. Melmed S (2011) Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7(5):257–266
4. Tichomirowa MA, Lee M, Barlier A, Daly AF, Marinoni I, Jaffrain-Rea ML, Naves LA, Rodien P, Rohmer V, Faucz FR, Caron P, Estour B, Lecomte P, Borson-Chazot F, Penfornis A, Yaneva M, Guitelman M, Castermans E, Verhaege C, Wémeau JL, Tabarin A, Fajardo Montañana C, Delemer B, Kerlan V, Sadoul JL, Cortet Rudelli C, Archambeaud F, Zacharieva S, Theodoropoulou M, Brue T, Enjalbert A, Bours V, Pellegata NS, Beckers A (2012) Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Endocr Relat Cancer 19(3):233–241
5. Taboada GF, Tabet AL, Naves LA, de Carvalho DP, Gadelha MR (2009) Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience. Pituitary 12(3):165–169
6. Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573
7. Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9(3):357–373
8. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189–3202
9. Vilar L, Naves LA, Costa SS, Abdalla LF, Coelho CE, Casulari LA (2007) Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly. Endocr Pract 13(4):363–372
10. Rodrigues MP, Naves LA, Casulari LA, Silva CA, Araújo RR, Viegas CA (2007) Using clinical data to predict sleep hypoxemia in patients with acromegaly. Arq Neuropsiquiatr 65(2A):234–239
11. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61–67
12. Dworakowska D, Grossman AB (2009) The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23(5):525–541
13. Jaffrain-Rea ML, Angelini M, Gargano D, Tichomirowa MA, Daly AF, Vanbellinghen JF, D’Innocenzo E, Barlier A, Giangaspero F, Esposito V, Ventura L, Arcella A, Theodoropoulou M, Naves LA, Fajardo C, Zacharieva S, Rohmer V, Brue T, Gulino A, Cantore G, Alesse E, Beckers A (2009) Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer 16(3):1029–1043
14. Villa C, Lagonigro MS, Magri F, Koziak M, Jaffrain-Rea ML, Brauner R, Bouligand J, Junier MP, Di Rocco F, Sainte-Rose C, Beckers A, Roux FX, Daly AF, Chiovato L (2011) Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer 18(3):347–356
15. Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás AF, Labarta Aizpún JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein MT, Vanbellinghen JF, Barra GB, Gimenez-Roqueplo AP, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SP, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95(11):E373–E383
16. Cannavò S, Ferraù F, Ragonese M, Curtò L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F (2010) Increased prevalence of acromegaly in a highly polluted area. Eur J Endocrinol 163(4):509–513
17. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619
18. Davis JR, Farrell WE, Clayton RN (2001) Pituitary tumours. Reproduction 121:363–371
19. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769–4775
20. Sesmilo G (2013) Epidemiology of Acromegaly in Spain. Endocrinol Nutr 60(8):470–474
21. Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T, Delemer B (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French acromegaly registry. Eur J Endocrinol 164(6):877–884
22. Petrossians P, Tichomirowa MA, Stevenaert A, Martin D, Daly AF, Beckers A (2012) The liege acromegaly survey (LAS): a new software tool for the study of acromegaly. Ann Endocrinol Paris 73(3):190–201
23. Rytkönen MJ (2004) Not all maps are equal: GIS and spatial analysis in epidemiology. Int J Circumpolar Health 63(1):9–24
24. Sinha G, Mark DM (2005) Measuring similarity between geospatial lifelines in studies of environmental health. J Geogr Syst 7:115–136
25. Jacquez GM, Greiling DA, Kaufmann AM (2005) Design and implementation of a space intelligence system for disease surveillance. J Geogr Syst 7:7–23
26. Foody GM (2006) GIS: health applications. Prog Phys Geogr 30:691–695
27. Boulus MN (2004) Towards evidence-based, GIS-driven national spatial health information infrastructure and surveillance services in United Kingdom. Int J Health Geogr 3:1
28. Meliker JR, Slotnick MJ, AvRusskin GA, Kauffmann A, Jacquez GM, Nriagu JO (2005) Improving exposure assessment in environmental epidemiology: application of spatio-temporal visualization tools. J Geogr Syst 7:49–66
29. Gao S, Mioc D, Anton F, Yi X, Coleman DJ (2008) Online GIS services for mapping and sharing disease information. Int J Health Geogr 7:8
30. Online document. Instituto Brasileiro de Geografia e Estatística (Brasil) Censo (2010) http://censo2010.ibge.gov.br
31. Online document Serviço geológico do Brasil www.cprm.gov.br
32. Online document Moura LHA (2008) Estudo geoquímico da bacia do Gama e avaliação da qualidade da água. Brasília (DF): Universidade de Brasília, Instituto de Geociências. http://repositorio.unb.br/bitstream/10482/5549/1/2008_LuizHenriqueAmorimMoura.pdf
33. IOM - Institute of Medicine (2009) Beyond the HIPAA privacy rule: enhancing privacy, improving health through research. The National Academics Press, Washington, DC, USA, US Department of Human Health Services, HIPAA Regulations §164.514
34. Armstrong MP, Rushton G, Zimmerman DL (1999) Geographically masking health data to preserve confidentiality. Stat Med 18:497–525
35. Gregorio D, DeChello L, Samociuk H, Kulldorff M (2005) Lumping or splitting: seeking the preferred areal unit for health geography studies. Int J Health Geogr 4:6
36. Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhães AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO, Rosa JW, Jaffrain-Rea ML, Bours V, Beckers A (2007) Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. Eur J Endocrinol 157(4):383–391
37. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? Rev Endocr Metab Disord 9(1):33–39
38. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol Oxf 41(1):95–102
39. Elebead FM, Hamid A, Hilmi HS, Galal H (2012) Mapping cancer disease using geographical information system (GIS) in Gezira State-Sudan. J Community Health 37(4):830–839
40. Yomralioglu T, Colak EH, Aydinoglu AC (2009) Geo-relationship between cancer cases and the environment by GIS: a case study of Trabzon in Turkey. Int J Environ Res Public Health 6(12):3190–3204